Related references
Note: Only part of the references are listed.Tuberculosis eradication: renewed commitment and global investment required
Helen Cox et al.
LANCET INFECTIOUS DISEASES (2018)
The global burden of tuberculosis: results from the Global Burden of Disease Study 2015'
Christopher J. L. Murray et al.
LANCET INFECTIOUS DISEASES (2018)
Persistently high early mortality despite rapid diagnostics for drug-resistant tuberculosis cases in South Africa
K. Schnippel et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2017)
Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa
Denise Evans et al.
PLOS ONE (2017)
Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implementation of Xpert MTB/RIF in South Africa: A retrospective cohort study
Helen Cox et al.
PLOS MEDICINE (2017)
Implications of Failure to Routinely Diagnose Resistance to Second-Line Drugs in Patients With Rifampicin-Resistant Tuberculosis on Xpert MTB/RIF: A Multisite Observational Study
Karen R. Jacobson et al.
CLINICAL INFECTIOUS DISEASES (2017)
The effect of early versus late treatment initiation after diagnosis on the outcomes of patients treated for multidrug-resistant tuberculosis: a systematic review
Rebecca C. Harris et al.
BMC INFECTIOUS DISEASES (2016)
Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort Study
Rebecca Berhanu et al.
PLOS ONE (2016)
Xpert MTB/RIF - why the lack of morbidity and mortality impact in intervention trials?
Andrew F. Auld et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2016)
Predictors of mortality and treatment success during treatment for rifampicin-resistant tuberculosis within the South African National TB Programme, 2009 to 2011: a cohort analysis of the national case register
Kathryn Schnippel et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2015)
Achieving high treatment success for multidrug-resistant TB in Africa: initiation and scale-up of MDR TB care in Ethiopia-an observational cohort study
Daniel Meressa et al.
THORAX (2015)
Programmatic treatment outcomes in HIV-infected and uninfected drug-resistant TB patients in Khayelitsha, South Africa
Erika Mohr et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2015)
Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF
Gavin J. Churchyard et al.
LANCET GLOBAL HEALTH (2015)
Impact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South Africa
Helen S. Cox et al.
OPEN FORUM INFECTIOUS DISEASES (2015)
Pre-treatment loss to follow-up in tuberculosis patients in low- and lower-middle-income countries and high-burden countries: a systematic review and meta-analysis
Peter MacPherson et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2014)
Impact of Introducing the Line Probe Assay on Time to Treatment Initiation of MDR-TB in Delhi, India
Neeta Singla et al.
PLOS ONE (2014)
Impact of Xpert MTB/RIF for TB Diagnosis in a Primary Care Clinic with High TB and HIV Prevalence in South Africa: A Pragmatic Randomised Trial
Helen S. Cox et al.
PLOS MEDICINE (2014)
Impact of Xpert MTB/RIF on Antiretroviral Therapy-Associated Tuberculosis and Mortality: A Pragmatic Randomized Controlled Trial
L. Mupfumi et al.
OPEN FORUM INFECTIOUS DISEASES (2014)
Comparing early treatment outcomes of MDR-TB in decentralised and centralised settings in KwaZulu-Natal, South Africa
M. Loveday et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2012)
Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study
Keertan Dheda et al.
LANCET (2010)
Treatment Outcomes and Long-term Survival in Patients with Extensively Drug-resistant Tuberculosis
Doh Hyung Kim et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Share Paper
